LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 24th Prioritisation – 3rd quarter 2015

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 24th Prioritisation – 3rd quarter 2015. HSO: 24th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
281Kb
Abstract

For the 24th prioritisation (September 2015), 7 were filtered out of 191 identified drugs and were sent to prioritisation. Of these, 2 drugs were ranked as 'highly relevant' by the expert panel, 4 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 24th Prioritisation
Deposited on:03 Nov 2015 16:26
Last Modified:24 Aug 2017 15:22

Repository Staff Only: item control page